News | Interventional Radiology | April 30, 2019

Data presented at Society of Interventional Radiology shows Avenu Medical’s device reduces procedure time, eliminates need for X-rays or contrast agents

Ellipsys Vascular Access System Preferred Technique for Endovascular AV Fistula Creation

April 30, 2019 — New data presented at the Society of Interventional Radiology (SIR) 2019 annual meeting showed the Ellipsys Vascular Access System was the preferred technique for performing endovascular AV fistula creation (endoAVF) compared to other approaches. Data on the U.S. Food and Drug Administration (FDA)-cleared device were presented by Robert Shahverdyan, M.D., head of the Vascular Access Center at Asklepios Klinik Barmbek in Hamburg, Germany.

Ellipsys, a minimally-invasive catheter-based system designed for end-stage renal disease (ESRD) patients requiring hemodialysis, provides physicians and patients access to a non-surgical option for AV fistula creation. In his presentation, Shahverdyan outlined the comparative benefits of using Ellipsys when compared to other available technology, including faster procedure time, no need for X-rays or contrast agents, and a simpler procedure to perform overall.

In addition to Shahverdyan’s presentation, another SIR 2019 study centered around the use of Ellipsys, titled “The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access.” The study was led by Jeffrey H. Hull, M.D. of Richmond Vascular Center, and was selected by the editors of the Journal of Vascular and Interventional Radiology (JVIR) as the Outstanding Clinical Study of the Year, the society’s top award. Hull’s paper was chosen by JVIR editorial board members from among hundreds of reviewed manuscripts published in 2018 and singled out as the most essential, best-in-class research conducted in interventional radiology in the last year.

For more information: www.avenumedical.com

Related Content

News | Lung Imaging

June 29, 2022 — Building on Penn Medicine’s years of research and use of imaging technology that illuminates tumor ...

Time June 29, 2022
arrow
News | Radiology Business

June 29, 2022 — Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed ...

Time June 29, 2022
arrow
News | Proton Therapy

June 27, 2022 — Varian, a Siemens Healthineers company, announced that the U.S. Food and Drug Administration (FDA) ...

Time June 28, 2022
arrow
News | Radiation Oncology

June 27, 2022 — Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they ...

Time June 28, 2022
arrow
News | Radiation Therapy

June 24, 2022 — Recently, a collaborated research team led by Prof. LI Hai and Hongzhi Wang from Hefei Institutes of ...

Time June 24, 2022
arrow
News | Contrast Media

June 23, 2022 — Supply chain disruptions have created critical shortages of Omnipaque (iohexol) and Visipaque (iodixanol ...

Time June 23, 2022
arrow
News | SIR

June 20, 2022 — SIR Foundation launched a program to enhance the scientific rigor of research into interventional ...

Time June 20, 2022
arrow
News | Interventional Radiology

June 17, 2022 — Parag J. Patel, MD, MS, FSIR, an interventional radiologist and professor of radiology at the Medical ...

Time June 17, 2022
arrow
News | Computed Tomography (CT)

June 16, 2022 — Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly ...

Time June 16, 2022
arrow
News | Interventional Radiology

June 13, 2022 — The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to ...

Time June 13, 2022
arrow
Subscribe Now